Position in KYMR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$85,446,577
+$36,065,688 QoQ
Shares Held
745,152
+25.7% QoQ
Ownership
0.896%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#23
of 275 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 84%
Shared 9%
None 6%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. KYMR ranks #20 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in KYMR
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $85,446,577 | 745,152 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $49,380,889 | 592,879 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $48,555,538 | 624,027 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $41,398,370 | 731,420 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $24,585,248 | 563,365 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $10,823,958 | 395,468 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $17,449,962 | 433,755 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $22,369,386 | 472,626 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $12,011,190 | 402,385 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $14,038,200 | 349,209 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $13,588,587 | 533,723 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $9,107,652 | 655,227 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $19,333,163 | 840,938 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $21,925,932 | 739,991 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,816,472 | 313,160 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $4,623,183 | 212,365 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,687,561 | 187,281 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $10,060,775 | 237,731 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,119,993 | 64,892 | Shares | Defined | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||